SCHEMBL29617720

SCHEMBL29617720

COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 16/20 1.00
▸ BTK Q06187 10/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18665653 1.00 EGFR (1.00) EGFRBTK
SCHEMBL18665651 0.90 EGFR (1.00) EGFRBTK
SCHEMBL29886851 0.88 BTK (0.84) EGFRBTK
SCHEMBL18665673 0.88 BTK (0.84) EGFRBTK
SCHEMBL24735215 0.86 EGFR (0.86) EGFRBTK
SCHEMBL18665608 0.86 EGFR (1.00) EGFRBTK
SCHEMBL29841335 0.86 EGFR (0.86) EGFRBTK
SCHEMBL31071137 0.86 EGFR (0.75) EGFRBTK
SCHEMBL25378572 0.85 EGFR (0.89) EGFRBTK
SCHEMBL31611556 0.85 EGFR (0.89) EGFRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4116303-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER Loxo Oncology, Inc. (US) 2023-01-11 — — EP disclosed
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 — — CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 — — CN disclosed
Send feedback